In February 2016, TriFoil Imaging in collaboration with GenMedica Baltic Ltd and assistance of BioVitrum Ltd installed Russia’s first 3D Optical imaging system, the InSyTe FLECT/CT. The system was installed under the operation of Prof. Evgeny Zavyalov, head of SPF Vivarium Department of Experimental Animal Genetic Resources the Federal Research Center Institute of Cytology and Genetics the Siberian Branch of the Russian Academy of Sciences.
Prof. Evgeny Zavyalov, head of SPF Vivarium, “There are similar systems but only this advanced system provides true 3D whole body optical imaging. The InSyTe FLECT/CT system will be used for experimental oncology. The optical imaging will allow for more detailed studies in the field of cardiology, neurology and other areas of science.”
The InSyTe from Trifoil provides true 360° tomographic optical preclinical imaging. This enables researchers to perform in vivo imaging of small animals in a compact, powerful benchtop system. The capabilities match that of nuclear imaging modalities such as PET and SPECT.
Read the full article by clicking on the link above.
The research facility at Bar Ilan University (BIU), Safed, Israel has installed a Triumph II PET/CT. This multi-modality imaging system is the first small animal imaging system to be installed at Bar ILan Faculty of Medicine in the Galilee. The system was installed under the operation of Prof. Izhak Haviv for cancer research.
“Through our distributor in Israel, Lavi MedTech we are honored to have been selected to provide BIU their first multi-modality small animal imaging system,” said TriFoil Director of Sales. “We look forward to working closely with BIU and Lavi to help facilitate any research or imaging they require in the future.”
Read the full press release by clicking the link above!
TriFoil Imaging is proud to announce the appointment of BioVitrum as its exclusive distributor in all regions of Russia and Kazakhstan
In collaboration with its Partner, GenMedica-Baltic, and in response to the growing demand for its digital preclinical nuclear and optical imagers, TriFoil Imaging is proud to announce the appointment of BioVitrum as its exclusive distributor in all regions of Russia and Kazakhstan. TriFoil Imaging is excited to work with BioVitrum, a fast-growing and well-established company in medical and laboratory equipment, renowned for promoting and supporting innovative products and technologies in Russia: http://www.biovitrum.ru/en/company/history.
TriFoil Imaging is excited to announce that the research facility at Latvian Institute of Organic Synthesis (IOS), Latvia, has installed an InSyTe FLECT/CT. This system was sold through TriFoil Imaging’s distributor in the CIS Countries and Scandinavia, GenMedica-Baltic. The system was installed under the operation of the IOS Laboratory of Pharmaceutical Pharmacology, Head Prof. Maija Dambrova, for drug discovery research.
Prof. Dambrova states: “With InSyTe FLECT/CT 360º system we will be able to study true anatomical displacement of small animals and accurately measure fluorophore concentrations throughout the region of interest. We will monitor the progression of atherosclerosis in aorta, ischemia-reperfusion or traumatic injury in the brain, permeability of vasculature and inflammation. In addition, we can evaluate the efficacy of the treatment when studying novel compounds. InSyTe FLECT/CT system could be used also by other laboratories/groups of IOS that are or will be interested in studying angiogenesis, apoptosis, cancer or infectious diseases.”
The first ever research article using the Triumph LabPET4 or any preclinical PET system in Brazil!
Antidepressant Effects of Ketamine Are Not Related to 18F-FDG Metabolism or Tyrosine Hydroxylase Immunoreactivity in the Ventral Tegmental Area of Wistar Rats
EXCERPT FROM ABSTRACT: “Major depressive disorder (MDD) is an important health problem that is often associated to stress. One of the main brain regions related to MDD is the ventral tegmental area (VTA), a dopaminergic center, part of the reward and motivation circuitry. Recent studies show that changes to VTA dopaminergic neurons are associated with depression and treatment. Ketamine has recently shown a fast, potent antidepressant effect in acute, sub-anesthetic doses. Thus, our aims were to elucidate if ketamine would be able to revert depression-like behaviors induced by a chronic unpredictable stress (CUS) protocol and if it could cause alterations to metabolism and tyrosine hydroxylase (TH)-immunoreactivity in VTA…”
Click on the link above to read the full article
AXT’s recently appointed Business Development Manager for in vivo Products Steve Hunter said, “The addition of TriFoil Imaging products to our range gives us a variety of imaging solutions second to none. Their innovative products are world-leading and we look forward to growing their user-base across Australia in the near future”